ALPS Key Statistics, Chart & Performance
The current stock price of ALPS is 0.92 USD. In the past month the price increased by 29.1%.
ALPS Latest News, Press Relases and Analysis
About ALPS
Company Profile
Alps Group Inc is a MY-based company operating in industry. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2025-10-31. Alps Group Inc is the parent company of Alps Life Sciences Inc., an integrated biotechnology platform integrating research and development, medical services, and wellness solutions of advanced therapies under one unified ecosystem aimed at improving healthcare outcomes globally. The firm has cultivated a diverse pipeline covering various biotechnology research areas. This includes initiatives focused on MyImmune (NK cells), CAR-T cells, COVID-19 mRNA vaccine, diabetes therapeutics, and advancements in stem cell technologies such as induced Pluripotent Stem Cells (iPSCs) and messenger ribonucleic acid (mRNA) platform technology. The firm provides aesthetic treatments, cosmetic procedures, general healthcare and wellness services. The Company’s aesthetic services and cosmetic surgery services include non-surgical aesthetic services and surgical aesthetic services. The company operates a molecular laboratory and a cGMP cell and gene therapy research and cultivation laboratory.
Company Info
ALPS GROUP INC
Unit E-18-01 & E-18-02, Level 18,, Icon Tower (East), No.1,Jalan 1/68F,
KUALA LUMPUR WILAYAH PERSEKUTUAN MY
Employees: 0
Phone: 60321631113
ALPS GROUP INC / ALPS FAQ
What does ALPS do?
Alps Group Inc is a MY-based company operating in industry. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2025-10-31. Alps Group Inc is the parent company of Alps Life Sciences Inc., an integrated biotechnology platform integrating research and development, medical services, and wellness solutions of advanced therapies under one unified ecosystem aimed at improving healthcare outcomes globally. The firm has cultivated a diverse pipeline covering various biotechnology research areas. This includes initiatives focused on MyImmune (NK cells), CAR-T cells, COVID-19 mRNA vaccine, diabetes therapeutics, and advancements in stem cell technologies such as induced Pluripotent Stem Cells (iPSCs) and messenger ribonucleic acid (mRNA) platform technology. The firm provides aesthetic treatments, cosmetic procedures, general healthcare and wellness services. The Company’s aesthetic services and cosmetic surgery services include non-surgical aesthetic services and surgical aesthetic services. The company operates a molecular laboratory and a cGMP cell and gene therapy research and cultivation laboratory.
What is the current price of ALPS stock?
The current stock price of ALPS is 0.92 USD. The price decreased by -10.68% in the last trading session.
What is the dividend status of ALPS GROUP INC?
ALPS does not pay a dividend.
What is the ChartMill rating of ALPS GROUP INC stock?
ALPS has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Should I buy ALPS stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ALPS.
What is the employee count for ALPS stock?
ALPS GROUP INC (ALPS) currently has 0 employees.
Can you provide the ownership details for ALPS stock?
You can find the ownership structure of ALPS GROUP INC (ALPS) on the Ownership tab.
ALPS Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to ALPS.
ALPS Financial Highlights
Over the last trailing twelve months ALPS reported a non-GAAP Earnings per Share(EPS) of -0.17. The EPS decreased by -216.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -25.77% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |